ABBONDANZA, Ciro
 Distribuzione geografica
Continente #
EU - Europa 2.999
NA - Nord America 2.419
AS - Asia 365
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
SA - Sud America 1
Totale 5.789
Nazione #
US - Stati Uniti d'America 2.406
IE - Irlanda 795
IT - Italia 786
UA - Ucraina 359
GB - Regno Unito 289
CN - Cina 248
DE - Germania 234
FR - Francia 184
SE - Svezia 135
FI - Finlandia 107
TR - Turchia 86
GR - Grecia 57
BE - Belgio 22
CA - Canada 11
IR - Iran 10
CH - Svizzera 7
NL - Olanda 6
PK - Pakistan 6
SG - Singapore 6
RO - Romania 5
AL - Albania 4
EU - Europa 4
IN - India 4
HU - Ungheria 3
JP - Giappone 3
AT - Austria 2
MX - Messico 2
AM - Armenia 1
AU - Australia 1
BR - Brasile 1
CZ - Repubblica Ceca 1
ES - Italia 1
IM - Isola di Man 1
LU - Lussemburgo 1
TW - Taiwan 1
Totale 5.789
Città #
Dublin 795
Jacksonville 545
Chandler 534
Ann Arbor 136
Caserta 116
Princeton 100
Bremen 91
Medford 72
Beijing 69
Boardman 69
Roxbury 67
Cambridge 64
Woodbridge 62
Rome 50
Naples 44
San Mateo 42
Ashburn 41
Wilmington 41
Nanjing 40
Düsseldorf 29
New York 27
Milan 26
Venice 25
Brussels 22
Nanchang 22
Des Moines 18
Napoli 17
Helsinki 15
Jinan 14
Shenyang 14
Mountain View 13
Auburn Hills 12
Kunming 12
Pozzuoli 12
Norwalk 10
Tianjin 10
Lanzhou 9
Hanover 8
Los Angeles 8
Salerno 8
San Nicola la Strada 8
Bari 7
Cerami 7
Hebei 7
Rockville 7
Zanjan 7
Poggiomarino 6
Frattaminore 5
Haikou 5
Piedimonte San Germano 5
Shanghai 5
Stella Cilento 5
Boscotrecase 4
Caivano 4
Florence 4
Guangzhou 4
Hangzhou 4
Mazara Del Vallo 4
Ningbo 4
Padova 4
Perugia 4
Portland 4
Ragusa 4
Taiyuan 4
Taizhou 4
Zhengzhou 4
Amsterdam 3
Andover 3
Atella 3
Bellinzona 3
Bologna 3
Casoria 3
Catania 3
Cava Dei Tirreni 3
Dearborn 3
Genoa 3
Kocaeli 3
Portici 3
Prato 3
Quartu Sant'elena 3
Sacramento 3
San Felice A Cancello 3
Sciacca 3
Seattle 3
Tokyo 3
Udine 3
Vancouver 3
West Jordan 3
Ancona 2
Ariano Irpino 2
Athens 2
Bacoli 2
Barano d'Ischia 2
Bassano del Grappa 2
Borås 2
Boston 2
Campagnano di Roma 2
Cesena 2
Changsha 2
Cittanova 2
Totale 3.529
Nome #
Analisi delle sottopopolazioni linfocitarie nel trattamento cortisonico 308
Immunità innata: le prime linee di difesa 144
Immunobiologia di Janeway 96
Le basi dell'immunologia. Fisiopatologia del sistema immunitario 93
Telaprevir may induce adverse cutaneous reactions by a T cell immune-mediated mechanism 84
C-Myc modulation and acetylation is a key HDAC inhibitor target in cancer 83
A 67 kDa non-hormone binding estradiol receptor is present in human mammary cancers 81
A novel p53 mutant in human breast cancer revealed by multiple SSCP analysis 80
Studio dell’interazione tra il recettore dell’estradiolo e proteine di estratti nucleari da HeLa ed MCF-7 78
An aprotinin binding site localized in the hormone binding domain of the estrogen receptor from calf uterus 77
Regulation of p53 function in normal and malignant cells 77
Estradiol receptor has proteolytic activity that is responsible for its own transformation 72
Induzione da acido retinoico (All-trans retinoico) della proteina RIZ 1, prodotto del gene oncosoppressore RIZ, in cellule di leucemia promielocitica 72
La capacità dell’ antioncogene p53 di legare specifiche sequenze di DNA è modulata in vitro dalla presenza di oligonucleotidi 71
Antiproliferative effects of SOM 230 in EPN prostate cell line 71
Characterization and epitope mapping of a new panel of monoclonal antibodies to estradiol receptor 70
Meccanismi effettori dell’immunità umorale 70
Estradiol induces functional inactivation of p53 by intracellular redistribution 69
Aprotinin inhibits the hormone binding of the estrogen receptor from calf uterus 69
In vitro binding of the purified hormone-binding subunit of the estrogen receptor to oligonucleotides containing natural or modified sequences of an estrogen-responsive element 69
Estrogens Modulate Somatostatin Receptors Expression and Synergizes With the Somatostatin Analog Pasireotide in Prostate Cells 69
17beta-estradiol-induced activation of ERK1/2 through endogenous androgen receptor-estradiol receptor alpha-Src complex in human prostate cells. 67
Proteolytic activity of the purified hormone-binding subunit of the estrogen receptor 67
L’acido all-trans retinoico e l’antiestrogeno ICI 182,780 promuovono apoptosi in cellule epiteliali estrogeno dipendenti (MCF-7) influenzando i livelli di Bcl-2 e p. 53 67
Antibodies anti-p53 serological detection with ELISA method. 66
Rosacea and abatacept: the first report of a possible correlation 66
Manifestazioni sistemiche dell'infiammazione (cap.16) 65
HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape. 63
In vitro binding of the purified hormone-binding subunit of the estrogen receptor to the estrogen responsive element of the vitellogenin gene 63
Detrimental effects of Bartonella henselae are counteracted by L-arginine and nitric oxide in human endothelial progenitor cells 62
Anti-p53 antibodies detection in cancer patients. 62
Searching for a putative mechanism of tumor-promoting function of RIZ2 in cancer models 62
Clinical features of a new acid-labile subunit (IGFALS) heterozygous mutation: anthropometric and biochemical characterization and response to growth hormone administration. 61
Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptorα and β 61
Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein 61
Short 5’protuding oligonucleotides enhance binding of p53 to specific DNA sequences 61
Purified estrogen receptor enhances in vitro transcription 61
ANTIPROLIFERATIVE EFFECTS OF SOM230 AND OCTREOTIDE IN EPN PROSTATE CELL LINE. 61
Silencing of YY1 downregulates RIZ1 promoter in human osteosarcoma 60
ANTI-ONCOGENIC ACTION OF ESTRADIOL IN EPN, A NONTRANSFORMED PROSTATE EPITHELIAL CELL LINE: EFFECTS ON TUMOR SUPPRESSORS RB AND RIZ1 60
Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2 59
Differentiation of myeloid cell lines correlates with a selective expression of RIZ protein 59
Identification of the Syrian hamster cardiomyopathy gene 59
Proteomic analysis of MCF-7 cell lines expressing the zinc-finger or the proline-rich domain of retinoblastoma-interacting-zinc-finger protein 59
4) Purification of the estrogen receptor from calf uterus cytosol 59
Studio preliminare dell’espressione di TIM1, TIM3 e GITR sui linfociti T CD4+ di soggetti T- linfopenici e in terapia con interferone alfa 58
Human PRDM2: Structure, function and pathophysiology 58
Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription 57
Transcriptional control by nuclear receptor 57
Interaction of vault particles with estrogen receptor in the MCF-7 breast cancer cell 56
Immunità Innata 56
Short 5’protuding oligonucleotides enhance binding of p53 to specific DNA sequences 56
PRDM Proteins: Molecular Mechanisms in Signal Transduction and Transcriptional Regulation 55
Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation 55
Metal binding sites of the estradiol receptor from calf uterus and their possible role in the regulation of receptor function 55
Steroid induced androgen receptor-oestardiol receptor ß- Src complex triggers prostate cancer cell proliferation 55
DNA strend breaks induce the formation of p53 protein stable complexes with p53 target site and modifyits protease sensitivity 55
Immunità innata: le prime linee di difesa 54
Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells. 52
Prostate cancer stem cells: the role of androgen and estrogen receptors. 52
Differential expression of cyclooxygenases in hypertrophic scar and keloid tissues 51
Detection of the Mr 110,000 lung resistance-related protein LRP/MVP with monoclonal antibodies 51
Identification of a DNA binding protein cooperating with estrogen receptor as RIZ (retinoblastoma interacting zinc finger protein) 50
Loss of estrogen receptor beta expression in malignant human prostate cells in primary cultures and in prostate cancer tissues 50
INTERACTION OF ESTROGEN RECEPTOR α WITH THE RETINOBLASTOMA-INTERACTING-ZING-FINGER GENE PRODUCT RIZ 50
EXPRESSION AND CELLULAR LOCALIZATION OF TUMOR SUPPRESSOR PROTEIN RIZ1 (RETINOBLASTOMA-INTERACTING ZINC-FINGER PROTEIN 1) IN PROSTATE TISSUES. 50
Gamma1- and gamma2-syntrophins, two novel dystrophin-binding proteins localized in neuronal cells 49
Serum anti-p53 antibodies and progression of hepatic diseases HCV related. 49
Mouse monoclonal antibodies against estrogen receptor 49
Retinoblastoma-Interacting Zinc-Finger protein (RIZ): un candidato tumor-suppressor effettore dell’azione degli estrogeni 49
Tumor suppressor protein RIZ1 expression is regulated by DHT in prostate epithelial cells 48
17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence 47
Identification and characterization of the protein product of the human homeotic gene c8 47
Piccoli oligonucleotidi attivano la funzione di p53 modificando la sua affinità per specifiche sequenze di DNA 47
ESTROGEN RECEPTOR α AND β EXPRESSION IN PRIMARY CULTURES OF NORMAL AND MALIGNANT PROSTATE EPITHELIAL CELLS . 47
Differentiation of Myeloid cell lines correlates with a selective expression of RIZ protein 46
Riz, Rb e p53, tre nuovi possibili markers dell’azione dell’estradiolo in cellule di carcinoma mammario 46
Regolazione dell’espressione di p53 p21(WAF-1/CIP1) e di Bcl-2 da parte dell’estradiolo, dell’acido all-trans retinico e dell’ICI 182,780 in cellule di carcinoma mammario 46
DIFFERENT EXPRESSION OF ESTROGEN RECEPTOR α AND β IN PRIMARY CULTURES OF NORMAL AND MALIGNANT HUMAN PROSTATE EPITHELIAL CELLS 46
The retinoblastoma-interacting zinc-finger protein RIZ is a downstream effector of estrogen action 45
Expression of PRDM1/BLIMP1 and PRDM2/RIZ in the activation of T CD4+ naïve limphocytes 45
ESPESSIONE DEL TUMOR SUPPRESSOR RIZ1 IN CELLULE EPITELIALI NORMALI E MALIGNE DI PROSTATA 44
Pan-cancer mutational and transcriptional analysis of the integrator complex 43
Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework 41
The Zn-finger domain of RIZ protein promotes MCF-7 cell proliferation 41
Decreased serum vascular endothelial growth Factor-D (VEGF-D) levels in metastatic patients with differentiated thyroid carcinoma. 40
A proteomic analysis of protein expression pattern of MCF-7 cell lines transfected with the zinc-finger and proline-rich domain of retinoblastoma-interacting zinc-finger protein 39
EXPRESSION OF RIZ1 TUMOR SUPPRESSOR IN NORMAL AND MALIGNANT PROSTATE EPITHELIAL CELLS 38
ESTROGEN RECEPTOR α and β EXPRESSION AND IMMUNOREACTIVITY IN NORMAL AND CANCER HUMAN PROSTATES 37
Retinoic acid impairs estrogen signaling in breast cancer cells by interfering with activation of LSD1 via PKA. 37
DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. 36
Identification of a functional estrogen-responsive enhancer element in the promoter 2 of PRDM2 gene in breast cancer cell lines 36
Estrogen Induces Looping Between Tumor Suppressor RIZ Gene Promoter 2 with Exon 9a 36
Oestrogenreceptor beta expression and immunoreacivity 35
PRDM Gene Products in Testicular Germ Cell Tumors 34
RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancer. 33
Multifaceted role of PRDM proteins in human cancer 33
Exploring the putative role of PRDM1 and PRDM2 transcripts as mediators of T lymphocyte activation 29
Highlighting chromosome loops in DNA-picked chromatin (DPC) 26
PR/SET domain family and cancer: Novel insights from the cancer genome atlas 25
Totale 5.916
Categoria #
all - tutte 18.635
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.635


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201939 0 0 0 0 0 0 0 0 0 12 9 18
2019/2020743 119 110 23 7 105 30 130 45 61 58 46 9
2020/2021910 77 14 102 58 159 20 126 95 23 122 86 28
2021/2022795 57 17 15 39 242 10 15 17 25 66 72 220
2022/20231.836 169 64 26 185 187 156 17 128 806 23 39 36
2023/2024627 77 34 48 100 186 64 38 48 18 14 0 0
Totale 5.960